JVMCX
Price
$26.89
Change
-$0.78 (-2.82%)
Updated
Feb 3 closing price
Net Assets
24.66B
TRVHX
Price
$18.98
Change
+$0.09 (+0.48%)
Updated
Feb 3 closing price
Net Assets
1.61B
Interact to see
Advertisement

JVMCX vs TRVHX

Header iconJVMCX vs TRVHX Comparison
Open Charts JVMCX vs TRVHXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$26.89
Change-$0.78 (-2.82%)
VolumeN/A
Net Assets24.66B
Nuveen Mid Cap Value I
Price$18.98
Change+$0.09 (+0.48%)
VolumeN/A
Net Assets1.61B
JVMCX vs TRVHX Comparison Chart in %
View a ticker or compare two or three
VS
JVMCX vs. TRVHX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Buy and TRVHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 24.7B vs. TRVHX (1.61B). TRVHX pays higher dividends than JVMCX: TRVHX (1.59) vs JVMCX (0.00). JVMCX was incepted earlier than TRVHX: JVMCX (14 years) vs TRVHX (10 years). JVMCX (1.86) is less costly to investors than TRVHX (0.58). JVMCX (49.00) and TRVHX (48.00) have comparable annual turnover. JVMCX has a lower initial minimum investment than TRVHX: JVMCX (1000) vs TRVHX (100000). TRVHX annual gain was more profitable for investors over the last year : 6.92 vs. JVMCX (3.34). JVMCX return over 5 years is better than : 15.97 vs. TRVHX (14.02).
JVMCXTRVHXJVMCX / TRVHX
Total Expense Ratio1.850.58319%
Annual Report Gross Expense Ratio1.860.58321%
Fund Existence14 years10 years-
Gain YTD5.1215.67990%
Front LoadN/AN/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets24.7B1.61B1,536%
Annual Yield % from dividends0.001.59-
Returns for 1 year3.346.9248%
Returns for 3 years6.9423.2130%
Returns for 5 years15.9714.02114%
Returns for 10 years61.8212.91479%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MENEF0.170.01
+4.94%
Mene Inc.
CSPCY4.980.21
+4.40%
CSPC Pharmaceuticals Group Ltd.
CYBQF1.40N/A
N/A
Cyberdyne Inc.
SRKE0.17N/A
N/A
Strake Inc.
PTKFY13.57-0.73
-5.07%
PT Kalba Farma TBK